Is Hepatitis A Vaccine Required?
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose 0.5 ml for children aged 1 year to 15 years, and in adult dose 1 ml.
2. Live attenuated vaccines based on H2 or LA-1 HAV strains: These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAVvaccination is 1 year.
The classification of Hepatitis A Vaccine includes Inactivated Vaccine, Live Attenuated Vaccine, and the sales proportion of Inactivated Vaccine in 2017 is about 70.8%, and the proportion is increasing trend from 2013 to 2018.
Inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose 0.5 ml for children aged 1 year to 15 years, and in adult dose 1 ml.
According to this study, over the next five years the Hepatitis A Vaccine market will register a 2.8% CAGR in terms of revenue, the global market size will reach US$ 770 million by 2024, from US$ 650 million in 2019. In particular, this report presents the global market share sales and revenue of key companies in Hepatitis A Vaccine business.
Download free PDF Sample copy of Hepatitis A Vaccine Market at https://www.qandqmarketresearch.com/report-sample/476630
Key Stakeholders of Hepatitis A Vaccine Market:
Hepatitis A Vaccine (Drugs/Medicine) Manufacturers
Hepatitis A Vaccine Market (Drugs/Medicine/Medical Equipment) Distributors/Traders/Wholesalers
Hepatitis A Vaccine Sub Component Manufacturers
The Hepatitis A Vaccine Market continues to witness a major demand-supply gap, with one of the major impediments being absence of certified Hepatitis A Vaccine Producers are continuing to innovate and invest at the mill level, meanwhile partnering with relevant industries for addressing the rising requirement.
A quick look at the industry trends and opportunities:
The Researches find out why sales of Hepatitis A Vaccine Market is projected to surge in the coming years. The study covers the trends that will strongly favor the industry during the forecast period, 2019 to 2025. Besides this, the study uncovers important facts associated with lucrative growth and opportunities that lie ahead for the Hepatitis A Vaccine industry.
In this study, the years considered to estimate the market size of Hepatitis A Vaccine Market is as follow:
History Year: 2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Download free PDF Sample copy of Hepatitis A Vaccine Market at https://www.qandqmarketresearch.com/report-sample/476630
Key Points from TOC:-
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hepatitis A Vaccine Consumption 2014-2025
2.1.2 Hepatitis A Vaccine Consumption CAGR by Region
2.2 Hepatitis A Vaccine Segment by Type
2.2.1 Inactivated Vaccine
2.2.2 Live Attenuated Vaccine
2.3 Hepatitis A Vaccine Consumption by Type
2.3.1 Global Hepatitis A Vaccine Consumption Market Share by Type 2014-2019
2.3.2 Global Hepatitis A Vaccine Revenue and Market Share by Type 2014-2019
2.3.3 Global Hepatitis A Vaccine Sale Price by Type 2014-2019
2.4 Hepatitis A Vaccine Segment by Application
2.4.1 Government Institution
2.4.2 Private Sector
2.5 Hepatitis A Vaccine Consumption by Application
2.5.1 Global Hepatitis A Vaccine Consumption Market Share by Application 2014-2019
2.5.2 Global Hepatitis A Vaccine Value and Market Share by Application 2014-2019
2.5.3 Global Hepatitis A Vaccine Sale Price by Application 2014-2019
3 Global Hepatitis A Vaccine by Players
3.1 Global Hepatitis A Vaccine Sales Market Share by Players
3.1.1 Global Hepatitis A Vaccine Sales by Players 2017-2019
3.1.2 Global Hepatitis A Vaccine Sales Market Share by Players 2017-2019
3.2 Global Hepatitis A Vaccine Revenue Market Share by Players
3.2.1 Global Hepatitis A Vaccine Revenue by Players 2017-2019
3.2.2 Global Hepatitis A Vaccine Revenue Market Share by Players 2017-2019
3.3 Global Hepatitis A Vaccine Sale Price by Players
3.4 Global Hepatitis A Vaccine Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Hepatitis A Vaccine Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Hepatitis A Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio CR3, CR5 and CR10 2017-2019
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Hepatitis A Vaccine by Regions
4.1 Hepatitis A Vaccine by Regions
4.1.1 Global Hepatitis A Vaccine Consumption by Regions
4.1.2 Global Hepatitis A Vaccine Value by Regions
4.2 Americas Hepatitis A Vaccine Consumption Growth
4.3 APAC Hepatitis A Vaccine Consumption Growth
4.4 Europe Hepatitis A Vaccine Consumption Growth
4.5 Middle East & Africa Hepatitis A Vaccine Consumption Growth
View full Report details and Table of Contents at https://www.qandqmarketresearch.com/reports/476630/hepatitis-a-vaccine-106
Similar Reports:- https://www.qandqmarketresearch.com/search-result/page/1?search=Hepatitis%20A
QandQ Market Research
Via dell'Archeologia 29,
Call us : +1 833 267 4156
Email : email@example.com
QandQ Market Research is a Market aggregator brand owned solely by Megamind Research Pvt Ltd., an India based company. QandQ Market Research is an online marketplace of research report published by leading market research agencies by collecting their global and regional market reports on 100+ industry verticals.
Our database includes 1,000,000+ market research reports from over 75 leading global publishers & in-depth market research studies of over 5000 micro markets. With vast years of experience in the research field and comprehensive information about the publishers and their respective industrial expertise, we have gained grass root knowledge about the gaps prevailing within the research industry. Using this, we enable our clients to compare comprehensive research studies of various publishers so that they can procure best researching solutions for their organization. With this, we wish to collaborate with top companies across globe in being a trusted name for their researching requirements.
QandQ Market Research constantly strives to expand its existing market report collection to give broader choices to its esteemed clients.Be it first time or every time, with our expertise in research offerings and wide range of publications, we ensure we deliver all your research needs.
We are available 24/7 to offer support to our customers. So contact us anytime for your specific research needs and we will get in touch immediately to help you find a market research report you need.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Is Hepatitis A Vaccine Required? here
News-ID: 1815161 • Views: 330
More Releases from QandQ Market Research
Leukemia Drugs and Treatment Market worth $13700 million USD in 2025
Leukemia Drugs and Treatment Market worth $13700 million USD in 2025 – Exclusive report by QandQ Market Research According to the new market research report "Leukemia Drugs and Treatment Market by Process, Grade, Application, Region - Global Forecast to 2025", published by QandQ market research, the Leukemia Drugs and Treatment Market is estimated to grow from $10100 USD million in 2018 and to $13700 USD million by 2025, at a CAGR
Sepsis Diagnostics Market
Sepsis Diagnostics Market by Type, Top Key Players, Size, Share, Growth, Trends - Opportunity, Analysis, Forecast 2024 Sepsis Diagnostics Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Sepsis Diagnostics industry with a focus on the Chinese market. The report provides key statistics on the market status of the Sepsis Diagnostics manufacturers and is a valuable source of guidance and
Kidney Transplant Market
Kidney Transplant Market describes its growth, size, share, Forecast and trends to 2025 Kidney transplant is the most commonly conducted transplant surgery worldwide. It has gained widespread popularity by improving the outcome of end-stage renal disease ESRD patients. With advances in kidney transplant methods and improvement in transplant success, a kidney transplant is now widely considered to be the best way of treating chronic kidney disease for many people. As the
Cloud Computing Services Market
Cloud Computing Services Market describes its growth, size, share, Forecast and trends to 2025 Cloud Computing Services Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cloud Computing Services industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cloud Computing Services manufacturers and is a valuable source of guidance and
More Releases for Hepatitis
Hepatitis E Therapeutics Pipeline Analysis 2018
Hepatitis E is a liver disease caused by infection due to a virus known as hepatitis E virus (HEV). This disease can cause swelling in liver. Some of the common symptoms are mild fever, feeling of tiredness, feeling sick to stomach, and belly pain. Download the sample report at: https://www.pharmaproff.com/request-sample/1029 The World Health Organization (WHO) estimates released in 2018 stated that, every year, an estimated 20 million HEV infections worldwide, leading to
Hepatitis Drugs Market Opportunity Assessment Study
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market. Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market The increasing incidences of various types of hepatitis, such as hepatitis B, and hepatitis C are playing a pivotal role in
Global Hepatitis A Vaccine Sales Market Report
In this report, the global Hepatitis A Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Hepatitis A Vaccine for these regions, from 2013
Hepatitis B Vaccines Market Growth Analysis 2021
Hepatitis B refers to an infectious disease that is caused by hepatitis B virus. Symptoms of this disease are not visible in initial stages and develop after few weeks only. Hepatitis B virus is transmitted by exposure to infectious blood or body fluids of an infected person. This disease may even occur from the birth. Hepatitis B may be caused by blood transfusions, healthcare setting, sharing razors and dialysis. Hepatitis
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Global Hepatitis C Drug Sales Market 2017
In this report, the Global Hepatitis C Drug Market 2017 is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Hepatitis C Drug for these regions, from 2012